作者: Y. Genzel , C. Dietzsch , U. Reichl
DOI: 10.1007/978-90-481-3419-9_109
关键词:
摘要: Each year discussions on sufficient preparedness against an influenza pandemic are coming up. Currently, several new approaches for the manufacturing of effective vaccines under investigation. These include, baculovirus systems recombinant vaccines, use virus like particles or introduction designer cells as host cells. Furthermore, processes using established continuous cell lines being licensed. The favorite at moment are: Vero and MDCK